We evaluated the efficacy of posaconazole against Candida tropicalis in a systemic infection model with immunosuppressed mice. Posaconazole at 50 mg/kg of body weight/day prolonged the survival of mice and reduced the fungal tissue burden of mice infected with any of the five strains tested, with the exception of one strain that had a high MIC against this drug. Our results demonstrate the efficacy of posaconazole in the treatment of invasive murine infection caused by C. tropicalis. Copyright © 2010, American Society for Microbiology. All Rights Reserved.
CITATION STYLE
Mariné, M., Pastor, F. J., & Guarro, J. (2010). Efficacy of posaconazole in a murine disseminated infection by Candida tropicalis. Antimicrobial Agents and Chemotherapy, 54(1), 530–532. https://doi.org/10.1128/AAC.01136-09
Mendeley helps you to discover research relevant for your work.